Valuation: Zai Lab Limited

Market Cap 2.92B 2.5B 2.34B 2.14B 4.02B 279B 4.07B 27.65B 10.78B 140B 10.96B 10.73B 464B P/E 2026 *
-11.5x
P/E 2027 * -12.1x
Enterprise Value 2.46B 2.11B 1.97B 1.81B 3.39B 236B 3.44B 23.32B 9.09B 118B 9.25B 9.04B 391B EV / Sales 2026 *
5.83x
EV / Sales 2027 * 4.46x
Free-Float
94.05%
Yield 2026 *
-
Yield 2027 * -
1 day-0.04%
1 week+0.42%
Current month+42.36%
1 month+27.00%
3 months+36.18%
6 months+29.79%
Current year+47.45%
1 week 24.64
Extreme 24.64
27.5
1 month 17.92
Extreme 17.92
27.5
Current year 15.96
Extreme 15.96
27.5
1 year 15.96
Extreme 15.96
35.45
3 years 13.48
Extreme 13.48
44.34
5 years 13.48
Extreme 13.48
152.82
10 years 13.48
Extreme 13.48
193.54
Manager TitleAgeSince
Chief Executive Officer 61 2014-03-31
Director of Finance/CFO 58 2023-07-06
President 62 2022-11-30
Director TitleAgeSince
Chairman 61 2014-03-31
Director/Board Member 83 2016-12-31
Director/Board Member 75 2016-12-31
Date Insider Type Main position Quantity % Market Cap.
8/14/26 Fiscal year

Chief Financial Officer

2,927 0.0003%
8/12/26 Other

Director

-85,060 0.0075%
8/12/26 Sell

Director

-8,506 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
-0.04%+0.42%-23.48%+9.79% 2.92B
+0.90%+3.80%+39.43%-1.22% 83.28B
+8.86%+129.20%+453.51%+30.65% 57.92B
-1.69%+23.30%-25.53%-36.93% 57.77B
-1.46%+0.19%-0.81%+29.66% 51.75B
+1.74%+4.43%+11.41%+172.02% 49.35B
+1.13%+3.31%+55.82%-18.22% 32.03B
+0.46%+6.37%+47.71%+96.99% 25.91B
+1.19%+9.17%+3.12%+228.73% 22.74B
-0.30%+4.45%+60.84%+124.17% 16.87B
Average +0.22%+18.46%+62.20%+63.57% 40.05B
Weighted average by Cap. +0.19%+24.79%+81.51%+46.98%

Financials

2026 *2027 *
Net sales 423M 362M 339M 310M 582M 40.44B 590M 4B 1.56B 20.31B 1.59B 1.55B 67.19B 569M 487M 456M 417M 783M 54.43B 794M 5.39B 2.1B 27.34B 2.14B 2.09B 90.44B
Net income -245M -210M -196M -180M -337M -23.45B -342M -2.32B -905M -11.78B -920M -900M -38.96B -187M -160M -150M -137M -257M -17.88B -261M -1.77B -690M -8.98B -702M -687M -29.71B
Net Debt -458M -392M -367M -336M -630M -43.79B -638M -4.33B -1.69B -22B -1.72B -1.68B -72.76B -381M -326M -305M -279M -524M -36.44B -531M -3.61B -1.41B -18.3B -1.43B -1.4B -60.54B
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change Volume
26-08-21 $26.01 -0.04% 1,002,166
26-08-20 $26.02 -2.62% 1,386,065
26-08-19 $26.72 +4.50% 1,729,450
26-08-18 $25.57 -0.27% 1,630,983
26-08-17 $25.64 -1.00% 1,359,116
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
26.01USD
Average target price
32.39USD
Spread / Average Target
+24.53%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ZLAB Stock